Plasma and hepatic lipid profiles in furazolidone-treated rats

Ali A. Al-Qarawi, Badreldin H. Ali*, Abdel Gayoum A. Abdel-Gayoum

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Rats were treated orally with furazolidone (FZ) at doses of 50, 100, and 200 mg/kg body weight for three consecutive days. The parameters determined in plasma included: Total cholesterol, high density (HDL) cholesterol, low-density (VLDL+LDL) cholesterol, triglycerol (TAG), phospholipids (PL), and lipoprotein lipase. In the liver, cholesterol, TAG and phospholipid concentrations were measured. At the lowest dose used, no statistically significant effect on any of these parameters in plasma or liver was observed. The drug, dose-dependently, increased the concentrations of total cholesterol, VLDL cholesterol, TAG and PL in plasma. The activity of lipoprotein lipase was significantly decreased by FZ by about 45%. The hepatic cholesterol concentration was not significantly affected by any of the doses used. However, doses of lee and 200 mg/kg produced fatty infiltration in the liver and significantly increased TAG level. The highest dose also decreased PL concentration.

Original languageEnglish
Pages (from-to)364-366
Number of pages3
JournalExperimental and Toxicologic Pathology
Issue number4
Publication statusPublished - 2000


  • Furazolidone
  • Hepatic lipid profiles
  • Lipid profiles, plasma d hepatic
  • Liver, lipid profiles
  • Plasma lipid profiles

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Toxicology
  • Cell Biology


Dive into the research topics of 'Plasma and hepatic lipid profiles in furazolidone-treated rats'. Together they form a unique fingerprint.

Cite this